Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells

被引:2
|
作者
Taylor, Rhonda L. [1 ,2 ]
Cruickshank, Mark N. [3 ]
Karimi, Mahdad [2 ]
Ng, Han Leng [1 ]
Quail, Elizabeth [2 ]
Kaufman, Kenneth M. [4 ,5 ]
Harley, John B. [4 ,5 ]
Abraham, Lawrence J. [1 ]
Tsao, Betty P. [6 ]
Boackle, Susan A. [7 ]
Ulgiati, Daniela [1 ]
机构
[1] Univ Western Australia, Ctr Genet Origins Hlth & Dis, Sch Pathol & Lab Med, Crawley, WA 6009, Australia
[2] Univ Western Australia, Sch Chem & Biochem, Biochem & Mol Biol, Crawley, WA 6009, Australia
[3] Univ Western Australia, Telethon Kids Inst, Crawley, WA 6009, Australia
[4] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[5] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA
[6] Univ Calif Los Angeles, Dept Med, Div Rheumatol, Los Angeles, CA 90024 USA
[7] Univ Colorado, Sch Med, Div Rheumatol, Aurora, CO USA
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
B cells; core promoter; CR2/CD21; molecular biology; transcription factor; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COMPLEMENT RECEPTOR 2; HUMAN LYMPHOCYTES-B; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; PLASMA-CELL; FACTOR E2A; CR-2; GENE; T-CELLS; C3D;
D O I
10.1038/cmi.2014.138
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complement receptor 2 (CR2/CD21) is predominantly expressed on the surface of mature B cells where it forms part of a coreceptor complex that functions, in part, to modulate B-cell receptor signal strength. CR2/CD21 expression is tightly regulated throughout B-cell development such that CR2/CD21 cannot be detected on pre-B or terminally differentiated plasma cells. CR2/CD21 expression is upregulated at B-cell maturation and can be induced by IL-4 and CD40 signaling pathways. We have previously characterized elements in the proximal promoter and first intron of CR2/CD21 that are involved in regulating basal and tissue-specific expression. We now extend these analyses to the CR2/CD21 core promoter. We show that in mature B cells, CR2/CD21 transcription proceeds from a focused TSS regulated by a non-consensus TATA box, an initiator element and a downstream promoter element. Furthermore, occupancy of the general transcriptional machinery in pre-B versus mature B-cell lines correlate with CR2/CD21 expression level and indicate that promoter accessibility must switch from inactive to active during the transitional B-cell window.
引用
收藏
页码:119 / 131
页数:13
相关论文
共 49 条
  • [31] Regulation by EBV of the expression of the two intracellular proteins which interact with the C3d/EBV receptor (CR2, CD21) in human B lymphocytes.
    Cassinat, B
    Drane, P
    Barel, M
    Balbo, M
    Bouillie, S
    Frade, R
    FASEB JOURNAL, 1996, 10 (06): : 2661 - 2661
  • [32] Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice
    Twohig, Jason P.
    Pappworth, Isabel Y.
    Sivasankar, Baalasubramanian
    Kulik, Liudmila
    Bull, Melanie
    Holers, V. Michael
    Wang, Eddie C. Y.
    Marchbank, Kevin J.
    MOLECULAR IMMUNOLOGY, 2009, 46 (10) : 2002 - 2013
  • [33] Premature expression of complement receptor type 2 (CR2/CD21) on pro-B cells in the bone marrow induces partial B cell deletion and results in defective peripheral immune responses by remaining cells
    Kulik, L
    Marchbank, KJ
    Haluszczak, C
    Morgan, BP
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 261 - 262
  • [34] Human lymphocyte shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23
    FremeauxBacchi, V
    Bernard, I
    Maillet, F
    Mani, JC
    Fontaine, M
    Bonnefoy, JY
    Kazatchkine, MD
    Fischer, E
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) : 1497 - 1503
  • [35] Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: Activation of phosphatidylinositol 3-kinase via a CD19-independent pathway
    Bouillie, S
    Barel, M
    Frade, R
    JOURNAL OF IMMUNOLOGY, 1999, 162 (01): : 136 - 143
  • [36] Pep34, a synthetic peptide whose sequence corresponds to the intracytoplasmic domain of the epstein-barr virus receptor (CR2, CD21), regulates human B lymphocyte proliferation triggered through CR2.
    Balbo, M
    Barel, M
    Bouillie, S
    Drane, P
    Cassinat, B
    Frade, R
    MOLECULAR IMMUNOLOGY, 1995, 32 (16) : 1295 - 1298
  • [37] Analysis of tandem E-box motifs within human Complement receptor 2 (CR2/CD21) promoter reveals cell specific roles for RP58, E2A, USF and localized chromatin accessibility
    Cruickshank, Mark N.
    Dods, James
    Taylor, Rhonda L.
    Karimi, Mandad
    Fenwick, Emily J.
    Quail, Elizabeth A.
    Rea, Alexander J.
    Holers, V. Michael
    Abraham, Lawrence J.
    Ulgiati, Daniela
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2015, 64 : 107 - 119
  • [38] CHARACTERIZATION OF THE HUMAN-COMPLEMENT RECEPTOR-2 (CR-2, CD21) PROMOTER REVEALS SEQUENCES SHARED WITH REGULATORY REGIONS OF OTHER DEVELOPMENTALLY RESTRICTED B-CELL PROTEINS
    RAYHEL, EJ
    DEHOFF, MH
    HOLERS, VM
    JOURNAL OF IMMUNOLOGY, 1991, 146 (06): : 2021 - 2026
  • [39] Intracellular signaling pathways triggered by activation of the Epstein-Barr virus receptor (gp140, CR2, CD21, EBV/C3dR) on cell surface of human B lymphocytes
    Frade, Raymond
    Lottin, Severine
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [40] Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase
    Barel, M
    Le Romancer, M
    Frade, R
    JOURNAL OF IMMUNOLOGY, 2001, 166 (05): : 3167 - 3173